Raymond Debbane - 30 Apr 2022 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
Director
Signature
/s/ Raymond Debbane
Issuer symbol
LXRX
Transactions as of
30 Apr 2022
Net transactions value
$0
Form type
4
Filing time
02 May 2022, 16:14:26 UTC
Previous filing
06 Apr 2022
Next filing
23 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise $0 +4,024 +1.2% $0.000000 331,545 30 Apr 2022 Direct
holding LXRX Common Stock 4,321,214 30 Apr 2022 By Invus Partners, LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise $0 -4,024 -100% $0.000000* 0 30 Apr 2022 Common Stock 4,024 $0.000000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock.